Oculeve
AcquiredOculeve was founded in 2011, is headquartered in San Francisco, United States, lists 11–50 employees, and has 3 recorded funding rounds.
- Headquarters
- San Francisco, California
- Employees
- 11–50
- Founded
- 2011
- Business Model
- B2B
- Last Round
- Series BMar 2014
- Rounds
- 3
- Acquired by
- AllerganJul 2015
Indexed holds 3 funding rounds and 4 investors for this company. The full record is or through the API.
About
Oculeve was a medical device company that developed TrueTear, a first-in-class non-invasive nasal neurostimulation device that activates the nasolacrimal pathway to stimulate natural tear production in patients with dry eye disease. Founded out of Stanford Biodesign, the company raised $24M before being acquired by Allergan in 2015 for $125 million upfront. The TrueTear device received FDA clearance and commercialized under Allergan.
Summary
Oculeve is a Biotech company based in San Francisco, United States, founded in 2011. It lists 11–50 employees. Its most recent funding was a Series B round in Mar 2014. Investors include Kleiner Perkins, Allergan and New Enterprise Associates.
Funding & Exit History
Jul 2015
Sign up to see all 4 events
Funding: Seed through Series B. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/oculeve"><img src="https://indexed.vc/api/badge/company/oculeve" alt="Oculeve on Indexed.vc" width="260" height="76" /></a>